Amazon (AMZN) says GLP-1 same-day delivery now available in 3,100 US cities, forecast to hit almost 4,500 by year end

Amazon (AMZN) says GLP-1 same-day delivery now available in 3,100 US cities, forecast to hit almost 4,500 by year end.

Amazon's buildout of prescription drug delivery extends a playbook it has run before: enter a regulated, logistics-intensive category, scale fulfilment density, and compress the incumbent's margin rather than chase near-term profit. Comparable expansions into groceries and pharmacy-adjacent categories have historically been read as long-dated share shifts rather than quarterly earnings drivers, with the immediate market reaction typically muted and the real effect showing up in the peer set over subsequent reporting periods. The transmission channel here runs through the pharmacy benefit and dispensing chain: same-day availability at this coverage level pressures the brick-and-mortar pharmacy cohort on convenience and the mail-order incumbents on speed, while for Amazon itself it is a Prime engagement and frequency story more than a standalone revenue line. The distinction worth drawing is between coverage announcements, which are cheap to make, and script volume disclosures, which are what has historically moved the needle for the affected peers. Worth noting on the calendar are the pharmacy and PDM peer prints, where management commentary on script retention and delivery mix has tended to be the first hard read on whether the threat is materialising.